Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

JHOP - April 2023 Vol 13, No 2

Case Reports

Original Article

Practical Issues in Pharmacy Management

FDA Oncology Update

Case Reports

Case Reports

Palbociclib-Induced Hepatotoxicity in a Patient with Metastatic Breast Cancer: A Case Report

Jennifer A. Hutchinson, PharmD, BCOP; Jenna Green, BS, PharmD; Christopher Jacques, PharmD; Ju Hee Kim, PharmD; Dana Haggett, MS, RN, FNP-BC; Olivia Straw, MSN, ACNP-BC, AOCNP; Jennifer Shin, MD, MPH

Case Reports

Novel Use of Ravulizumab in Transplant-Associated Thrombotic Microangiopathy: Case Report

Manuel R. Gonzales, MD; Jason C. White, DO; Kimberly A. Davidow, MD; David S. Mangum, MD; Kailey E. Grimm, PharmD, BCPPS

Original Article

Original Article

Evaluation of Outcomes in Patients Who Received Bevacizumab for the Treatment of Brain Radionecrosis

Jameshia A. Below, PharmD; Alina Khan, PharmD; Amanda Brahim, PharmD, BCOP, BCPS, BCACP; Luis E. Raez, MD, FACP, FCCP; Paola Izquierdo, RN, BSN, APRN, FPBC

Original Article

Incidence and Severity of Neuropathy with Concurrent Use of Voriconazole and Vincristine in Pediatric Patients with Cancer

Ashley Sabus, PharmD, BCOP; Mya Merrow, PharmD, BCOP; Ellen Burke, PharmD, BCOP; Gordon Kordas, MS; Megan Williams, PharmD; Maria Larson, PT, DPT, PCS; Kristen Eisenman, MD

Original Article

Safety of SC Daratumumab in the Treatment of Plasma-Cell Disorders: A Single-Center Experience

Jung Kye, PharmD, BCOP; Samit Patel, PharmD, BCOP; Maggie Seyer, PharmD, BCPS; Eun-Jeong Kim, PharmD, MS, BCOP; Rhonda Hewitt, MSN, ANP, AOCNP; Michaela Liedtke, MD; David Iberri, MD

Practical Issues in Pharmacy Management

Practical Issues in Pharmacy Management

Oral Chemotherapy Program Metrics: Results of a National Survey

Olivia G. Fahey, PharmD, BCOP; Sally Y. Barbour, PharmD, BCOP, CPP, FHOPA; Mary A. Golf, PharmD, BCOP; Darcy K. Malard Johnson, PharmD; Rachael M. Morgan, PharmD, BCOP; Melissa J. Rhoades, PharmD, BCOP; Kate D. Taucher, PharmD, MHA, BCOP, FASHP; John M. Valgus, PharmD, MHA, BCOP

FDA Oncology Update

FDA Oncology Update

FDA Approved Zynyz for Metastatic or Recurrent Locally Advanced Merkel-Cell Carcinoma

FDA Oncology Update

FDA Approved Tafinlar plus Mekinist for Pediatric Patients with BRAF V600E Mutation–Positive Low-Grade Glioma

FDA Oncology Update

FDA Granted Jemperli Regular Approval for dMMR Endometrial Cancer

FDA Oncology Update

FDA Expanded Eligibility for Verzenio plus Endocrine Therapy in Patients with Early Breast Cancer

FDA Oncology Update

Trodelvy Now FDA Approved for HR-Positive, HER2-Negative Breast Cancer